Vivani Medical Cofounder and CEO Adam Mendelsohn, Ph.D. discusses the company’s first application of the NanoPortal, ...
The implant is engineered to offer PER-001’s sustained release, aiming for a “convenient” dosing frequency of every six ...
The FDA has approved updated labeling for Sublocade (buprenorphine extended-release) injection to include a rapid induction protocol and alternative injection sites.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback